FDA Approved: ONDANSETRON — Supplemental Application (ACTAVIS PHARMA, INC.)

View source ↗

Summary

FDA approved a supplemental application for ondansetron from Actavis Pharma, updating the approved product under the existing NDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting
• Postoperative Nausea and Vomiting

Drugs mentioned

• Ondansetron (ondansetron)

Snippet

SUPPL AP for ONDANSETRON (ONDANSETRON)